Project Grant R03CA273478
Award Date
8/24/23
Completion Date
7/31/25
Dollars Obligated
$157K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research program) to Emory University aims to investigate the biological and social determinants of psychosocial sequelae in advanced head and neck cancer patients receiving immunotherapy. The total award amount is $664,304.00 over the project period from August 27, 2024 to June 30, 2029. The research objectives are to: 1) understand the psychosocial burdens experienced by advanced head...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) provides $1,500,000.00 to the University of Rochester to conduct research on the pathways by which key aspects of social connectedness in social networks (structural characteristics, functional aspects, and quality of relationships) interact and are associated with clinically significant health behaviors of older adults with advanced cancer. The research will focus on three...
This $1,073,982 National Cancer Institute project grant will fund research at Washington University in University City, Missouri from January 2023 through December 2027 under the Cancer Cause and Prevention Research program (CFDA 93.393). The research aims to document unmet social needs among 300 patient-caregiver dyads where the patient has breast or gynecologic cancer. It will analyze how social needs affect biopsychosocial outcomes for patients and caregivers, including depressive symptoms,...
The federal Project Grant award with ID R42CA295106 was granted by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393). The award, totaling $1,909,966.00, supports the development and evaluation of a digital social care referral platform called ConnectedNest by Xanthoshealth, Inc. The ConnectedNest platform aims to address the impact of social determinants of health on individuals facing cancer. Following a successful Phase I SBIR and pilot...
The National Cancer Institute (NCI) awarded a $455,111 Project Grant under CFDA 93.393 "Cancer Cause and Prevention Research" to the Sloan-Kettering Institute for Cancer Research in New York. The 2-year grant, awarded on September 5, 2023, will support research to "Leverage the Hidden Genome to Recover the Missing Heritability of Cancer." The project aims to 1) estimate additional heritability that can be explained by the "hidden genome" (regions of unknown...
The National Cancer Institute (NCI) awarded Virginia Commonwealth University (VCU) a $577,778 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) federal grant program. The grant will fund a Phase IIb randomized waitlist-controlled trial to assess the feasibility and acceptability of recruitment strategies, target population, and appropriateness of a waitlist control group for the FEARLESS protocol - a novel mindfulness-based psychological intervention targeting fear of...
The National Cancer Institute (NCI) awarded a $200,000 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The grant, awarded on September 15, 2023, supports research to develop novel therapeutic approaches to remediate radiotherapy-induced bone necrosis in oropharyngeal cancer patients, particularly among African-American populations who...
This federal Project Grant award of $334,233, awarded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program, will support a comprehensive research study examining disparities in novel cancer therapies, the joint effects of cancer treatment and comorbidities, and multi-level contributors to cancer survival outcomes. The University of South Carolina, the prime awardee, will conduct innovative data linkages between the state cancer registry,...
This Project Grant award from the National Cancer Institute (NCI), under the federal Cancer Cause and Prevention Research program (CFDA 93.393), provides $1,239,420 to the University of Maryland, Baltimore (UMB) to conduct a longitudinal observational study on the role of interoception (the brain's processing of internal bodily sensations) in chemotherapy-induced peripheral neuropathy (CIPN) in 120 patients with breast or gastrointestinal cancer. The study, which will also include 60 age-matched...
The National Cancer Institute (NCI) awarded a $256,487 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to the Sloan-Kettering Institute for Cancer Research in New York, NY. The purpose of this 5-year grant is to develop multimodal predictive models that integrate real-world data from circulating tumor DNA (ctDNA) sequencing, radiomics, tumor registries, and tissue genomics to improve risk stratification and clinical management of non-small cell lung cancer (NSCLC). The...